Octreotide subcutaneous depot for acromegaly: A randomized, double-blind, placebo-controlled phase 3 trial, ACROINNOVA 1.
Ferone D, Freda P, Katznelson L, Gatto F, Kadioğlu P, Maffei P, Seufert J, Silverstein JM, Spencer-Segal JL, Isaeva E, Dreval A, Harrie M, Svedberg A, Tiberg F.
Ferone D, et al. Among authors: gatto f.
J Clin Endocrinol Metab. 2024 Oct 8:dgae707. doi: 10.1210/clinem/dgae707. Online ahead of print.
J Clin Endocrinol Metab. 2024.
PMID: 39378125